| Like August said, I'm sure the investors are watching this carefully. A cure would mean a loss of hundreds, if not, thousands of jobs, in the diabetes care industry for Type 1 diabetes.
I thought it was interesting that one of the articles said that it may help Type 2 diabetes, as well. I suspect this was added to help receive more funding, since Type 2 is where the money is at. Deus also said he's being cautiously optimistic. I thought I'd see a lot more people saying the same. I guess it's been a while since we've seen any "new great news," and with it being a holiday season, it's hard to show skepticism.
There are several kinds of Type 1 diabetes, to my understanding. I wonder which "kind" this would work. I'd also like to know the "link" between this research and Dr. Faustman's (with the spleen cells) -- how is the biology related -- could they be triggering the same mechanism?
Another question to answer is, why do we form antibodies that are indicative of the presence of Type 1 diabetes? These antibodies tend to disappear or show up in a less significant quantity in people who have had Type 1 for several years (thus making this test not useful unless the person has recently been diagnosed).... so, how could we explain the antibody formation if this is a neurological basis? And why is there a significant link between Type 1 (autoimmune) and other autoimmune conditions, such as thyroid and even gluten sensitivity? Are these conditions colinked by coincidence, then?
I can't wait until we hear more. I would love to know the researchers behind the story, too -- are these scientists well-known and respected, or are they up and new-comers who are looking for money and a quick buck before they admit the results cannot be confirmed by other labs?
I'll have to admit, I had a lot of excitement when reading this, but after a few hours of trying to connect the science, there are just too many holes.
But you'd better believe I'll be in line with the rest of you for the cure if it works. |